MedTrace Logo

Comparison Between Effect of Acetazolamide and NaHco3 in Prevention of Contrast Nephropathy

NCT00634491 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2008-03-13

No results posted yet for this study

Summary

The purpose of this study is whether Acetazolamide is effective in prevention of contrast nephropathy

Conditions

  • Contrast Induced Nephropathy

Interventions

DRUG

sodium bicarbonate

150 meq/l Sodium bicarbonate 3cc/kg/hr before and 1cc/kg/hr after angiography

DRUG

Acetazolamide

Acetazolamide 250 mg+ 1 cc/kg/hr normal salin before and after angiography

DRUG

normal salin

1 cc/kg/hr 6 hour before and after angiography

Sponsors & Collaborators

  • Fars Heart Foundation

    collaborator UNKNOWN

  • Shiraz University of Medical Sciences

    lead OTHER

Principal Investigators

  • Maryam Pakfetrat, MD · Shiraz nephro-urology research center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2008-02-29
Completion
2008-02-29

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00634491 on ClinicalTrials.gov